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Abstract
According to the model for passive transport across the membranes, the total flow of permeant molecules is related to the
product of the water^membrane partition coefficient and the diffusion coefficient, and to the water^membrane interfacial
barrier. The effect of membrane surface charge on the permeability and interaction of analgesic peptide ligands with model
membranes was investigated. A mixture of zwitterionic phospholipids with cholesterol was used as a model membrane. The
lipid membrane charge density was controlled by the addition of anionic 1-palmitoyl-2-oleoylphosphatidylserine. Two classes
of highly potent analgesic peptides were studied, c[D-Pen2,D-Pen5]enkephalin (DPDPE) and biphalin, a dimeric analog of
enkephalin. The effect of increased surface charge on the permeability of the zwitterionic DPDPE is a relatively modest
decrease, that appears to be due to a diminished partition coefficient. On the other hand the binding of the dicationic biphalin
ligands to membranes increases proportionally with increased negative surface charge. This effect translates into a significant
reduction of biphalin permeability by reducing the diffusion of the peptide across the bilayer. These experiments show the
importance of electrostatic effects on the peptide^membrane interactions and suggest that the negative charge naturally
present in cell membranes may hamper the membrane transport of some peptide drugs, especially cationic ones, unless there
are cationic transporters present. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
A crucial step in the development of peptide based
opioid ligands for therapeutic purposes is the design
of ligands with desirable biological properties
coupled with the proper biophysical properties to
permit access from the blood to receptor sites in
the brain. The primary objective of this research is
to determine the nature of the interaction of receptor
selective opioid ligands with lipid bilayer membranes.
In doing so we seek to elucidate which molecular
characteristics of peptide and peptidomimetic ligands
may be modi¢ed to increase the membrane perme-
ability of these ligands.
It is accepted that interaction of peptides with
membranes arises from both hydrophobic and elec-
trostatic e¡ects [1^5]. The Gouy^Chapman theory
(see [6,7] for reviews) has been successfully applied
to describe the electrostatic interactions of peptides
with membranes [1,2,5,8,9], and it has been shown
that applicability of the Gouy^Chapman theory de-
pends on the distribution of charge on the membrane
surface and its distance from the membrane [10]. Ac-
cording to the Gouy^Chapman theory, the non-spe-
ci¢c electrostatic interaction may enhance peptide
solubility in the di¡use double layer. An experimen-
0005-2736 / 02 / $ ^ see front matter ß 2002 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 0 1 ) 0 0 4 2 1 - 7
* Corresponding author. Fax: +1-520-621-8407.
E-mail address: dfobrien@u.arizona.edu (D.F. O’Brien).
BBAMEM 78182 11-12-01
Biochimica et Biophysica Acta 1558 (2002) 45^53
www.bba-direct.com
tal manifestation of this e¡ect is an increase in the
peptide partition coe⁄cient [5,8,11].
According to the di¡usion model for the mem-
brane transport, permeability coe⁄cients are related
to the product of the water^membrane partition co-
e⁄cient of the permeant and the normal component
of the di¡usion coe⁄cient [12]. Di¡usional properties
of the membrane are strongly heterogeneous and the
partitioning process between water and membrane is
more complex than that between water and a non-
polar solvent [3]. At least two distinct regions can
be identi¢ed, the highly polar interface and hydro-
carbon interior [12]. To identify the rate-limiting
domain it is necessary to analyze partitioning and
di¡usion within these regions. Di¡usivity and parti-
tioning in the bilayer strongly depend on the perme-
ant size and shape [13,14] and models have recently
been developed [15,16].
This report is part of a study of the relations be-
tween opioid peptide structure, the energetics of in-
teraction with the membrane, and the membrane per-
meability. The general formalism for permeation is
outlined elsewhere [12,13,17]. The permeability coef-
¢cient, P, is proportional to the di¡usion coe⁄cient,
D, and partition coe⁄cient, K :
P  DK
X
1
where X is the membrane thickness.
The water^membrane partition coe⁄cient is de-
¢ned as K = [Cmem]/[Cr], where [Cmem] and [Cr] are
the concentration of the solute in the membrane and
in the bulk solvent, respectively. This model treats
the membrane as a homogeneous non-polar medium,
whereas the actual £ux across a membrane is also
dependent on interactions of the solute with the
phospholipid headgroups, or the membrane surface,
constituting an interface between aqueous and non-
polar phases. Experimentally the observed perme-
ability coe⁄cient re£ects both intramembrane and
interfacial processes [12]:
P31 
Z
x
1
DxKxdx R 2
where R is the interfacial resistance. Its dimension is
that of a reciprocal permeation coe⁄cient, and both
di¡usion and partition coe⁄cients are functions of
position in the membrane, x. This relationship indi-
cates that transmembrane drug delivery can be en-
hanced by: (i) increasing water^membrane partition-
ing, (ii) increasing the di¡usion constant within a
membrane interior, and/or (iii) controlling the inter-
facial resistance of the membrane. Previously, we
have focused on (i), increased peptide partitioning,
as a tool to increase permeability [18,19]. The parti-
tion coe⁄cient is dependent on the free energy
change upon the water-to-membrane transfer, and
therefore can be related to the thermodynamics of
peptide^solvent and intramolecular interaction, char-
acteristics that appear to be controllable by an ap-
propriate molecular design.
In this study we analyze how the surface charge,
contributing to the interfacial resistance (iii) a¡ects
the transmembrane £ow of two classes of enkephalin
analogues. These peptides represent di¡erent ap-
proaches in the design of biologically active peptides:
the biphalins, which are £exible dimeric peptides,
that are among the most potent analgesic enke-
phalin analogues [20^22]; and the conformationally
constrained cyclic enkephalin analogues, the c[D-
Pen2,D-Pen5]enkephalins (DPDPEs) [23,24]. Both
peptides and their analogues were previously studied
in this laboratory [18,19,25,26]. By comparative anal-
ysis of the parent peptides, along with their modi¢-
cations, we are able to infer speci¢c mechanisms for
peptide permeation across phospholipid bilayers.
2. Materials and methods
The following lipids: 1,2-dipalmitoylphosphati-
dylcholine, 1-palmitoyl-2-oleoylphosphatidylcholine
(POPC), 1-palmitoyl-2-oleoylphosphatidylethanol-
amine (POPE), 1-palmitoyl-2-oleoylphosphatidylser-
ine (POPS), and cholesterol were obtained from
Avanti Polar Lipids and used to prepare lipid bi-
layers. HEPES and HEPPS were purchased from
Calbiochem, sodium azide and sodium chloride
from Aldrich, cholesterol and Triton TX-100 from
Sigma. Degassed HEPES bu¡er (10 mM HEPES,
150 mM sodium chloride, 1 mM sodium azide, 0.1
mM EDTA, pH 7.4) or HEPPS bu¡er (10 mM
HEPPS, 150 mM sodium chloride, 1 mM sodium
azide, 0.1 mM EDTA, pH 8.9) was used throughout
the experiments. Dialysis membranes were purchased
from Spectrum, Houston, TX, USA. Liposomes were
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prepared from 20 mg of a dried mixture of lipids and
cholesterol hydrated in 1 ml of bu¡er and vigorously
stirred to form homogeneous dispersion. The disper-
sion was frozen and thawed 10 times to form ex-
tended bilayers, which were then extruded at 45‡C
through Nuclepore ¢lters with a pore size of 200
nm [27]. Predominantly unilamellar liposomes of uni-
form size and narrow polydispersity were formed as
shown by quasi-elastic light scattering (QELS) and
supported by negative stain electron microscopy [25].
2.1. Permeability assay
Liposomes for this assay were prepared in a
HEPPS bu¡er (pH 8.9), that contained the peptides.
These circumstances impart a negative surface charge
to POPC, POPE and cholesterol liposomes that min-
imizes liposome aggregation at high lipid concentra-
tions when the chromatography is initiated. Lipo-
somes, with trapped peptides, were separated from
untrapped peptides by size exclusion chromatogra-
phy on a Sephacryl S-300 column. A 2 ml fraction
of liposome suspension was placed in a dialysis mem-
brane bag, and the pH was adjusted to 7.4. The pH
gradient across the lipid bilayer relaxes several orders
of magnitude faster than the peptide permeation
[19,25]. The dialysis was performed at 25‡C as de-
scribed by Romanowski et al. [19]. The amount of
peptide molecules released from the vesicles into the
dialysate was determined by a £uorescamine assay
[28]. The permeability data were analyzed by the
procedure of Johnson and Bangham [29] which
yields the following equation:
ln
NVout
V in  V out3Nt
 
 ln NVout
V in  Vout3k
Vout  V in
Vout
t
3
where N(t) is the number of peptide molecules in
dialysate at a given time, N is the number of peptide
molecules in liposomes at time = 0, Vout is the volume
of the dialysate, Vin is the volume of the liposome
suspension contained in the dialysis bag and, ¢nally,
k = (A/V)P, where A is the surface area of the inside
liposomes, V is the internal volume of the liposomes
and P is the permeability coe⁄cient. The number of
peptide molecules initially trapped in the liposomes
was estimated by the following procedure. The lipo-
somes were sized by dynamic light scattering [30].
The apparent liposome diameter with entrapped pep-
tides varied between 146 and 155 nm. The lipid con-
tent was determined by the ammonium ferrothiocya-
nate assay [31]. The total liposome volume was
calculated from the average liposome diameter to-
gether with the total lipid content. Finally, the pep-
tide concentration inside the liposomes was assumed
to be equal to the initial concentration of peptides in
the lipid suspension before extrusion, thereby giving
the trapped amount of peptide, N. Eq. 3 allows for
calculation of the permeability coe⁄cient, P, by the
method of least squares. The above method is not
corrected for any peptide that resides in the lipid
bilayer phase, the magnitude of this error is similar
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or less than the uncertainties cited in Table 1, as
discussed previously [19].
2.2. Equilibrium dialysis
We have developed an equilibrium dialysis assay
to determine partitioning of the opioid peptides be-
tween the aqueous phase and model membranes [19].
This experimental method also allows for determina-
tion of thermodynamic characteristics of the parti-
tioning process, such as van’t Ho¡ enthalpy and
entropy of peptide transfer. Each dialysis cell is
separated by a cellulose dialysis membrane, average
MW cut o¡ 12 000^14 000. One milliliter of ca. 0.1
mM peptide solution in bu¡er is placed on the cis
side of the membrane, whereas 1 ml of a liposome
suspension in the same bu¡er is placed on the trans
side. Liposomes for this assay were prepared in
HEPES bu¡er (pH 7.4), without peptides. Dialysis
is performed overnight in a water bath, using ¢ve
cells mounted in a rotor that ensures homogeneity
of peptide and lipid distribution in the dialysis cells.
In the experiments performed, the lipid concentra-
tion was varied from 0 to 40 mM. Concentrations
of peptides on the cis side (therefore unbound) are
determined by measurements of the intrinsic peptide
£uorescence (all peptides under study contain tyro-
sine). Data are analyzed using a non-saturable parti-
tioning model, which yields the partition coe⁄cient:
I0
I
 K L
2W  1 4
where I is the intensity of £uorescence, I0 is the in-
tensity of £uorescence in the cell with no lipids on
the trans side, [L] is the concentration of lipids, [W] is
the concentration of water, and K is the partition
coe⁄cient. The described method actually measures
the water^membrane partition coe⁄cient, where the
membrane phase includes both the non-polar interior
and any possible associations of the solute with the
lipid headgroups.
3. Results
The lipids used in this study to prepare liposomes
were either a mixture of POPC, POPE and choles-
terol in the molar ratio 65:25:10, or the same lipids
plus POPS as indicated in Tables 1 and 2. The com-
positions approximate those of neutral or anionic
lipid membranes, respectively. The published phase
diagrams of PC^cholesterol mixtures indicate that
the lipid bilayer is in the liquid disordered phase
when the cholesterol content is between 10 and
20 mol% and the temperature is at least 15‡C above
the main phase transition temperature (Tm) of the
phospholipid [32,33]. Since the Tm values for POPC
and POPE are below or near room temperature, re-
spectively [34], and there is no evidence of a phase
transition in the POPC:POPE:cholesterol mixture up
to 60‡C, it appears reasonable that the model mem-
branes used in these studies exist in the liquid disor-
dered phase at the experimental temperature. POPS
lipid was chosen to introduce the negative charge to
the model membrane. It has been shown that binding
of short (up to ¢ve amino acid residues) basic pep-
tides does not exhibit speci¢city between PS and PG
lipids [8].
The permeability of the bilayer membranes to var-
ious solutes may be measured by dialysis of the lipo-
some-entrapped solute provided the rate of permea-
tion through the dialysis bag, which in this case was
Table 1
Permeability of selected peptides across neutral and anionic membranes
Peptide Permeability coe⁄cient (10312 cm/s)
0% POPS 10% POPS
DPDPE(SH)2 3.24 þ 0.39 2.88 þ 0.56
[D-Phe3]DPDPE 2.91 þ 0.38 2.40 þ 0.44
DPDPE 0.38 þ 0.11 0.30 þ 0.08
[p-F-Phe4;4
0
]Biphalin 2.58 þ 0.67 1.20 þ 0.23
[(2S,3R)L-Me-Phe4;4
0
]Biphalin 1.63 þ 0.15 0.50 þ 0.06
Biphalin 0.68 þ 0.15 0.21 þ 0.19
Permeability coe⁄cients determined using POPC:POPE:cholesterol liposomes, with or without addition of anionic POPS.
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ca. 1034 cm s31, is much larger than the rate through
the bilayer. The peptide concentration in the bu¡er
was assayed by the rapid reaction of the peptide
amino group with £uorescamine to yield highly £uo-
rescent derivatives (excitation 380 nm, emission 475
nm). The partition coe⁄cient was determined by
equilibrium dialysis, using the intrinsic £uorescence
of peptides, due to tyrosine (excitation 275 nm, emis-
sion 305 nm) or tryptophan (excitation 285 nm, emis-
sion 340 nm). This method allows for determination
of partition coe⁄cients of ca. 100 or greater, which is
similar to the limit of other methods based on equi-
librium dialysis [4]. The apparent partition coe⁄-
cient, as determined in these experiments, does not
di¡erentiate between peptides that penetrate into the
membrane interior and those that merely adsorb at
the membrane surface.
3.1. Peptide structures
The permeability coe⁄cients of selected peptides
are listed in Table 1. Along with the parent com-
pounds, DPDPE and biphalin, the other peptides
represent di¡erent modi¢cations known to increase
permeability across neutral membranes. Those mod-
i¢cations include more hydrophobic side chains
(Gly3^Phe3 replacement in DPDPE, [Phe3]DPDPE);
methylation of Phe4;4
0
in biphalin ([(2S,3R)L-Me-
Phe4;4
0
]-biphalin), halogenation of Phe4;4
0
in biphalin,
and removing conformational restrictions in DPDPE
by reducing the D-Pen2,D-Pen5 disul¢de bridge
(DPDPE(SH)2). These modi¢cations also increase
the peptide permeability across anionic membranes;
however, the permeability coe⁄cients of biphalins
and DPDPEs decrease when the anionic lipid is
added (Table 1). This change is more signi¢cant for
the dicationic biphalins, where the addition of 10%
of POPS reduces the permeability coe⁄cients to less
than 50% of its initial value, whereas in the zwitter-
ionic DPDPEs the analogous change is much less. In
the latter case the decrease may not be statistically
di¡erent than the permeability of a neutral mem-
brane.
The magnitude of the change is similar for each
peptide within a class, i.e. DPDPEs or biphalins.
Thus the permeability of the DPDPEs is decreased
to a similar extent whether the peptide is cyclic or
acyclic. The addition of the tryptophan residue in
position 6 increases the partition coe⁄cient of
DPDPE and its reduced acyclic form, as expected
Table 2
Water^membrane partition coe⁄cient of DPDPE analogues
Peptide Partition coe⁄cient, K Ratio K10%/K0%
0% POPS 10% POPS
[L-Trp6]DPDPE(SH)2 1240 þ 100 820 þ 70 0.66
[L-Trp6]DPDPE 800 þ 80 580 þ 60 0.73
DPDPE(SH)2 780 þ 70 380 þ 50 0.48
DPDPE 155 þ 10 6 100 6 0.67
[p-F-Phe4;4
0
]Biphalin 2190 þ 180 3610 þ 200 1.65
Biphalin 860 þ 80 1350 þ 150 1.56
Partition coe⁄cients determined using POPC:POPE:cholesterol liposomes, with or without addition of anionic POPS.
Fig. 1. E¡ect of increasing anionic content on the membrane
permeability of [(2S,3R)2PL-diMe-Tyr4;40 ]biphalin (b) and [p-F-
Phe4;4
0
]biphalin (R). Permeability coe⁄cients, P, were deter-
mined using POPC:POPE:cholesterol liposomes and the anionic
content was controlled by addition of POPS, 0^15 mol%. 10
mol% POPS corresponds to approximately 0.025 C/m2.
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from the hydrophobic character of tryptophan (Ta-
ble 2). The water^membrane partition coe⁄cient of
DPDPE and analogues is lower for the anionic mod-
el membrane than for the neutral one (Table 2), in-
dicating that fewer peptide molecules enter the neg-
atively charged membranes. This observation
suggests an explanation for the diminished perme-
ability of DPDPEs across the membrane. In contrast
to the zwitterionic DPDPEs, the partition coe⁄cient
of the dicationic biphalins is greater for anionic
rather than neutral membranes. This is consistent
with the postulated electrostatic nature of peptide^
interface interaction. Here the electrostatic attraction
forces adsorb biphalin at the membrane surface.
However, the electrostatic attraction does not in-
crease the transmembrane £ux of the dicationic pep-
tides.
To further analyze the contribution of interfacial
interactions to the overall permeation process we
analyzed the permeability coe⁄cients of [p-F-
Phe4;4
0
]biphalin and [(2S,3R)2PL-diMe]Tyr4;40-bipha-
lin as a function of the fraction anionic lipid,
POPS, in the bilayer membranes. The permeability
coe⁄cient of these peptides decreases with added
anionic lipids (Fig. 1), linear correlation coe⁄cients
being 30.9908 and 30.9951, respectively. A similar
type of analysis shows that the partition coe⁄cient
[p-F-Phe4;4
0
]biphalin increased as the fraction of
anionic lipid increased (Fig. 2), linear correlation co-
e⁄cient = 0.9961. These results suggest that the neg-
ative surface charge of the model membrane reduces
the transmembrane £ux of the dicationic peptides
by increasing the population of electrostatically ad-
sorbed peptides.
4. Discussion
Our e¡orts to date have concentrated on the mod-
i¢cations intended to a¡ect the population of ana-
logues within a membrane, treated as a homogeneous
medium, with the implied assumption that this is the
rate-limiting process of the overall transmembrane
transport. Introducing a membrane surface charge,
that can be controlled by the fraction of anionic
phospholipids such as POPS, can provide insights
into the nature of membrane^water interfacial bar-
rier and help to determine the limiting step of the
transmembrane movement of selected peptides.
Understanding the rate-limiting step of transmem-
brane transport is very important for the future de-
sign of therapeutic peptides. Peptide £ux limited by
the membrane interior can be enhanced by, for ex-
ample, increased hydrophobicity of this analog,
whereas £ux limited by the interfacial barrier may
require modi¢cation of a cation/anion equilibrium
and distribution within the peptide. We previously
demonstrated that the conformational £exibility of
a ligand promotes its transfer across the membrane
[19,25]. Our data show that permeability of di¡erent
peptide classes require di¡erent bases of comparison
related to the hydrophobicity of the amino acids [18].
The analysis of peptide permeability across anionic
model membranes, as shown here, demonstrates
the importance of peptide^membrane electrostatic
interactions for design of permeable therapeutic
agents.
A qualitative analysis of electrostatic interactions
between peptide and membrane can be described by
means of the electrostatic potential. Following the
Gouy^Chapman approximation [6,7,11] the surface
potential of uniformly charged membrane surface is
given by:
Fig. 2. Comparison of the partition coe⁄cient, K, and the per-
meability coe⁄cient, P, as the anionic lipid (POPS) content is
increased from 0, 5, to 10 mol%. Both partition and permeabil-
ity coe⁄cients were determined for p-F-Phe4;4
0
-biphalin with
POPC:POPE:cholesterol liposomes, with the addition of POPS
to control the anionic content of the membrane.
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i 0  cVOO 0 5
where c is the surface charge density and V is the
Debye screening length. The spatial pro¢le of the
electrostatic potential can be then computed within
the framework of the Gouy^Chapman approxima-
tion as follows:
i x  i 0exp3x=V  6
where x is the distance from the membrane surface.
The local concentration [C(x)] of any Z-valent ion
present in the aqueous phase can be calculated using
the Boltzmann equation, provided the electric poten-
tial i(x) is known.
The anionic lipid mixture used in the experiments
that contain 10 mol% of negatively charged lipids
corresponds to a surface charge density c=30.025
C/m2 = 64131 e/Aî 2. The Debye screening length V at
the room temperature was estimated following Cevc
[11] : V= 0.304/Z[C]1=2 = 0.785 nm, where [C] = 150
mM is the concentration of monovalent (Z = 1)
NaCl in bu¡er. According to Eq. 6, the surface po-
tential of the uniformly charged liposome equals
326.4 mV.
The experimental data clearly shows a very di¡er-
ent e¡ect of the membrane surface charge on the
partitioning of DPDPEs and biphalins. The partition
coe⁄cient of biphalin increases, whereas that of
DPDPE decreases with addition of negatively
charged lipids to the membrane, since at pH 7.4 these
peptides show the opposite ionic character. Qualita-
tively, biphalin carries a positive charge whereas
DPDPE is negative. Biphalin contains two amino
termini due to tyrosines, with typical pKa for depro-
tonation of -NH3 of 9. At pH 7.4 the overall char-
acter of biphalin is essentially dicationic (Z = +2) due
to the two amino termini. DPDPE contains two ion-
izable groups, the amino terminus of tyrosine in po-
sition 1, and the carboxyl terminus of penicillamine
in position 5. The approximate pKa for deprotona-
tion of -COOH is 1.8. It appears that the anionic
character of DPDPE can be explained by the fact
that the average pKa = 5.5 is below the pH of the
experiments.
In our experiments the concentration of the pep-
tides was low (ca. 0.1 mM) compared to the concen-
tration of NaCl in bu¡er (150 mM). Therefore the
spatial pro¢le of the electrostatic potential within the
Gouy^Chapman approximation (Eq. 6) can be reli-
ably computed using the NaCl concentration alone.
The concentration of peptides as a function of the
peptide valency, Z =31, 0, +2, was calculated ac-
cording to the Boltzmann distribution. Under the
conditions used in the experiments (bu¡er containing
150 mM NaCl and liposomes containing 10% nega-
tively charged lipids) this analysis predicts that at
1 nm from the membrane surface the concentration
of dicationic peptide (Z = 2) such as biphalin, is 1.89
times greater than that of a neutral compound. On
the other hand, the concentration of an anionic pep-
tide (Z =31) is 0.73 that of a neutral compound.
The data presented in Table 2 indicates that the
partition coe⁄cient of biphalin increases by a factor
of ca. 1.6 when going from neutral to negatively
charged (10 mol% PS) membranes. The partition co-
e⁄cient of DPDPEs (except the acyclic analog) is
reduced by a factor of 0.7. Both of these observa-
tions are in good agreement with the predicted val-
ues. The water^membrane partition coe⁄cient is in-
dependent of the peptide concentration in the bulk
phase. However, a local change of the peptide con-
centration at the membrane surface induced by the
electrostatic interaction will a¡ect the apparent par-
tition coe⁄cient measured in the bulk phases. Let
[Pmem] = K0[Pface] de¢ne the intrinsic partition coe⁄-
cient K0, where [Pmem] and [Pface] are molar concen-
trations of peptides in the membrane and in the
aqueous phase at the arbitrarily de¢ned interfacial
distance N. The measured (bulk phase) partition co-
e⁄cient is equal to:
K  Pmem=Pr  K0Pface=Pr 
K0exp3ZFi N =RT 7
where the last equation combines the Boltzmann
equation and Gouy^Chapman approximation,
[Pface] = [Pr]exp(ZFi(N)/RT) and K0 = K in the ab-
sence of the electric ¢eld. Therefore the experimen-
tally observed changes of the partition coe⁄cient are
directly proportional to the changes of the peptide
concentration at the interfacial distance from the
membrane. This observation suggests a simple em-
pirical relation between ionic character of peptide,
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expressed by its valency Z, and the peptide partition
coe⁄cient. However, an experimental data analysis
by the method of best ¢t to the above expression
led to the conclusion that the e¡ective valency Z is
lower than that deduced from the structure of the
solute [2]. This appears to be a common observation
for ionic peptides [35].
The proton concentration within the vicinity of a
negatively charged membrane surface is higher than
bulk solution. Qualitatively, this e¡ect shifts the
anion/cation equilibrium at the membrane surface
toward more positively charged species, as compared
to those present in the bulk phase. This e¡ect how-
ever is partially screened by the salt present in water
and by the distance from the membrane surface. At
the surface of a liposome that contains 10 mol%
negatively charged lipids and immersed in a 150
mM solution of monovalent salt, the pH value would
be 0.45 less than bulk pH. The same e¡ect at 1 nm
from that membrane surface lowers the pH by 0.12,
compared to the bulk value, which does not seem to
be a signi¢cant change.
We have discussed how the anionic character of
membranes may in£uence the local concentration
of peptides and how in turn this concentration con-
trols the partition coe⁄cient. Finally, we shall exam-
ine the model of di¡usion controlled membrane per-
meability, Eq. 2. Previously we analyzed the relation
between the partition coe⁄cient and permeability co-
e⁄cient of a series of enkephalin analogues interact-
ing with a neutral model membrane [18,19]. We
found good correlation between these quantities,
consistent with the model given by Eq. 2. However,
introducing the electrostatic charge results in changes
of the permeability coe⁄cient that seem to be related
to the di¡usion across the interfacial barrier rather
than partition coe⁄cient itself.
As pointed out by Diamond and Katz [12], per-
meation in biological membranes depends on equi-
librium solute partition, solute mobilities in the mem-
brane interior and interfacial rate processes. The
permeation of DPDPE across neutral and anionic
membranes seems to be predominantly controlled
by the partition coe⁄cient (Tables 1 and 2). In the
case of biphalin, the permeability decreases while the
electrostatic attraction increases the number of pep-
tides associated with membrane, as evident from the
comparison of partition and permeability data (Ta-
bles 1 and 2). We assume that the electrostatically
controlled layer is characterized by a relatively slow
di¡usion rate creating a kinetic barrier for the trans-
membrane movement, therefore preventing these
molecules from penetrating and crossing the mem-
brane. Another possibility is that the addition of
the anionic lipids changes the organization of lipid
molecules within the model membrane, rendering the
membrane less permeable for any type of solute,
anionic, cationic, or neutral. It has been shown how-
ever that lateral packing density and molecular area
of charged and uncharged lipids in the £uid state are
essentially the same [36], suggesting that organization
of lipid molecules remains similar in anionic and
neutral model membranes.
In conclusion, the strong correlation between the
ionic character of peptides, the anionic lipid content
of the model membrane, and the observed partition
coe⁄cients suggest that electrostatic interactions con-
trol the water^membrane partition of the enkephalin
peptides by electrostatic repulsion or attraction
forces. However, the addition of anionic lipids to
the membrane composition decreases the permeabil-
ity of the peptides, both zwitterionic and dicationic.
This observation suggests that the electrostatic at-
traction of the dicationic peptide at the water^mem-
brane interface reduces the transmembrane £ux of
such peptides by creating a kinetic barrier. The ob-
served e¡ects indicate that the anionic lipids natu-
rally present in cell membranes may reduce the trans-
port of some peptide drugs across the membrane.
Our results suggest that by controlling the isoelectric
point of the peptide one can partially overcome this
di⁄culty. The e¡ect of the negatively charged mem-
brane surface is much smaller for zwitterionic pep-
tides (such as DPDPE) than for dicationic ones (bi-
phalins). This observation explains why the span
between biphalin and DPDPE permeability coe⁄-
cients, obtained with neutral liposomes, diminishes
in experiments in vitro, using bovine brain microves-
sel endothelial cell systems [37].
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